Skip to main content
OpenTrials

Clinical trial condition

Purpura, Thrombocytopenic, Idiopathic

Explore clinical trials studying Purpura, Thrombocytopenic, Idiopathic. Study availability and eligibility vary by location and protocol.

321 public trials 83 recruiting studies
Refine in advanced search Browse all conditions

Purpura, Thrombocytopenic, Idiopathic trial results

Recruiting

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

NCT06722235

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • USC Norris Comprehensive Cancer Center - Keck Medicine of USC Los Angeles, California, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • Georgetown University Medical Center - Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States
  • Emory University Atlanta, Georgia, United States
View all 114 locations
View Trial Details
Recruiting

A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)

NCT07194850

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +22 more
Locations
  • Centre Hospitalier Universitaire de Bordeaux Groupe Hospitalier Pellegrin Hopital des Enfants Bordeaux, France
  • Charite - Universitaetsmedizin Berlin - Campus Virchow-Klinikum (CVK) Berlin, Germany
  • Gaslini Children's Hospital Genoa, Italy
  • Fondazione IRCCS San Gerardo dei Tintori Monza, Italy
View all 20 locations
View Trial Details
Recruiting

A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia

NCT06721013

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Stanford University Stanford, California, United States
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • University of Miami Hospital and Clinics Sylvester Comprehensive Cancer Center Miami, Florida, United States
View all 45 locations
View Trial Details
Recruiting

Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment

NCT07007962

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Community Health Partners (CHP) - Community Medical Oncology Specialists (University Oncology Associates) Clovis, California, United States
  • University of Southern California (USC) Los Angeles, California, United States
  • Tulane University Health Sciences Center - Tulane Avenue-Investigational Site Number: 8400011 New Orleans, Louisiana, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
View all 36 locations
View Trial Details
Recruiting

IASO-782 in Autoimmune Hematological Diseases

NCT06534021

Conditions
Autoimmune Diseases, Autoimmune Thrombocytopenia, Blood Coagulation Disorders, +17 more
Locations
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
  • Institute of Hematology, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
View Trial Details

Related conditions